Innate T cells learn to find their activating ligands in the skin during their thymic education using cholesterol byproducts

先天 T 细胞在胸腺教育过程中利用胆固醇副产物学会寻找皮肤中的激活配体

基本信息

  • 批准号:
    9763936
  • 负责人:
  • 金额:
    $ 25.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-01-21 至 2020-12-31
  • 项目状态:
    已结题

项目摘要

Innate T cells learn to find their activating ligands in the skin during their thymic education using cholesterol byproducts Summary Aberrant skin inflammatory disorder such as atopic dermatitis (AD) is a rampant disease among children of developed countries, with as many as a quarter of them afflicted. AD is known to be a disease of allergic T cells that manifest when the skin barrier becomes degraded. There has been progress in identifying genes involved in tissue barrier fortification. People with mutations in these genes are predisposed towards allergic diseases mediated by lymphocytes, but most individuals with genetic susceptibility still do not develop the diseases, suggesting that there exist immune mechanisms to dampen harmful inflammatory responses. We discovered that an absence of dermal innate T lymphocytes programmed to secrete IL-17 and IL-22 results in spontaneous AD in mice with all major hallmarks of human AD, placing these cells called Tγδ17 as the apex regulator of skin homeostasis. Murine dermal Tγδ17 cells develop only during neonatal stages and they are made in the thymus so that they can respond fast when they seed the skin. However, how these skin regulatory cells localize to the dermis is not known. In this project we will test the hypothesis that developing Tγδ17 cells learn to localize in the relevant skin sites in the thymus. This thymic education occurs by restricting maturation of Tγδ17 thymocytes that can sense cholesterol byproducts oxysterols via the G protein coupled receptor (GPCR) GPR183 (Ebi2) and/or the CCR6 chemokine receptor ligand CCL20. In non-inflammatory settings, such as in healthy neonates, GPR183+CCR6+ Tγδ17 cells exit the thymus and enter the skin using CCR6 and then fine-localize in the dermis using the putative oxysterol gradient. This is a high risk and high reward project, designed to establish the critical importance of oxysterols for innate T cell positioning in the body. The conceptual basis is unique as there are no precedents for the GPCR- dependent maturation of lymphocytes in the tissues of origin that are intimately linked to the ability of mature lymphocytes to anticipate the same cues in the tissues of function. This lack of precedent makes the project risky, but if proven to be accurate will fundamentally alter our understanding of mucosal innate T cell sensing of environmental alterations and expand the functional domains of cholesterol and its byproducts in building and maintaining a healthy immune system, especially in newborns.
先天T细胞学习在皮肤中找到它们的激活配体 利用胆固醇副产品进行胸腺教育 摘要 特应性皮炎(AD)等异常皮肤炎症性疾病是一种常见的疾病 在发达国家的儿童中,多达四分之一的儿童患有这种疾病。广告 已知是一种过敏性T细胞疾病,当皮肤屏障变成 降级了。在识别与组织屏障有关的基因方面取得了进展 设防。携带这些基因突变的人容易过敏 由淋巴细胞介导的疾病,但大多数有遗传易感性的人仍然 不发展的疾病,这表明存在免疫机制,以抑制 有害的炎症反应。我们发现,缺乏皮肤上的先天T细胞 分泌IL-17和IL-22的淋巴细胞导致小鼠自发性阿尔茨海默病 利用人类AD的所有主要特征,将这些名为Tγδ17的细胞放置在顶端 皮肤动态平衡调节剂。小鼠皮肤Tγδ17细胞仅在新生期发育 阶段,它们是在胸腺中制造的,所以当它们播种到 皮肤。然而,这些皮肤调节细胞如何定位于真皮尚不清楚。在这 我们将测试这一假设,即发育中的Tγδ17细胞学习定位于 胸腺中的相关皮肤部位。这种胸腺教育是通过限制成熟来进行的。 Tγδ17胸腺细胞中可通过G蛋白感知胆固醇副产物氧合甾醇 偶联受体GPR183(EBI2)和/或CCR6趋化因子受体配体 CCL20。在非炎症性环境中,如健康新生儿,GPR183+CCR6+ Tγδ17细胞通过CCR6离开胸腺进入皮肤,然后在胸腺中进行精细定位 真皮使用假定的氧固醇梯度。这是一个高风险、高回报的项目, 旨在确定氧化甾醇对先天T细胞定位的关键重要性 身体。概念基础是独一无二的,因为没有GPCR的先例- 起源组织中紧密相连的淋巴细胞的依赖成熟 成熟淋巴细胞在组织中预测相同线索的能力 功能。这种缺乏先例的做法使该项目具有风险,但如果被证明是准确的,将会 从根本上改变我们对粘膜固有T细胞感知的理解 环境变化与胆固醇及其功能域的拓展 建立和维护健康的免疫系统的副产品,特别是在 新生儿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joonsoo Kang其他文献

Joonsoo Kang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joonsoo Kang', 18)}}的其他基金

Identification of lung resident innate lymphocytes that specifically protect neonates from SARS-CoV-2 infections
鉴定可特异性保护新生儿免受 SARS-CoV-2 感染的肺固有淋巴细胞
  • 批准号:
    10742495
  • 财政年份:
    2023
  • 资助金额:
    $ 25.13万
  • 项目类别:
Parsing cholesterol metabolite regulation of skin immunocytes in children to identify archetypes of human neonatal immune system
解析儿童皮肤免疫细胞的胆固醇代谢调节,以确定人类新生儿免疫系统的原型
  • 批准号:
    10435128
  • 财政年份:
    2022
  • 资助金额:
    $ 25.13万
  • 项目类别:
Parsing cholesterol metabolite regulation of skin immunocytes in children to identify archetypes of human neonatal immune system
解析儿童皮肤免疫细胞的胆固醇代谢调节,以确定人类新生儿免疫系统的原型
  • 批准号:
    10595606
  • 财政年份:
    2022
  • 资助金额:
    $ 25.13万
  • 项目类别:
RUNX:CBFb complex constrains fetal-restricted innate T cell generation from adult lymphopoietic progenitors
RUNX:CBFb 复合物限制成人淋巴细胞祖细胞产生胎儿限制的先天 T 细胞
  • 批准号:
    10328570
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17
胆固醇代谢物协调以先天真皮 γδ T 细胞为中心的皮肤屏障免疫,这些细胞被编程为产生 IL-17
  • 批准号:
    10514621
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17
胆固醇代谢物协调以先天真皮 γδ T 细胞为中心的皮肤屏障免疫,这些细胞被编程为产生 IL-17
  • 批准号:
    10366952
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
RUNX:CBFb complex constrains fetal-restricted innate T cell generation from adult lymphopoietic progenitors
RUNX:CBFb 复合物限制成人淋巴细胞祖细胞产生胎儿限制的先天 T 细胞
  • 批准号:
    10195780
  • 财政年份:
    2021
  • 资助金额:
    $ 25.13万
  • 项目类别:
Identification and single cell analysis of embryonic lymphoid progenitors that generate neonatal innate T cells
产生新生儿先天 T 细胞的胚胎淋巴祖细胞的鉴定和单细胞分析
  • 批准号:
    10159863
  • 财政年份:
    2019
  • 资助金额:
    $ 25.13万
  • 项目类别:
SOX4 and SOX13 control early steps of invariant NKT cell differentiation
SOX4 和 SOX13 控制恒定 NKT 细胞分化的早期步骤
  • 批准号:
    8709664
  • 财政年份:
    2014
  • 资助金额:
    $ 25.13万
  • 项目类别:
Gene circuits programming IL-17 production in innate lymphocytes
基因电路编程先天淋巴细胞中 IL-17 的产生
  • 批准号:
    9194376
  • 财政年份:
    2013
  • 资助金额:
    $ 25.13万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了